that excessive exposures to the dust of lead
chromate pigments, lead-molybdenum chromate
pigments, and zinc chromate pigments could
have a relationship with causation of lung
cancer;
by the means above described; and
of the existing OSHA regulation will be
continued.
It has been decided to send similar notification to pigments customers of the manufacturing companies.
The recent publications which have prompted this decision at this time are:
- Langard, Sverre and Tor Norseth. A Cohort
Study of Bronchial Carcinomas in Workers
Producing Chromate Pigments, Brit. Jour.
Indus. Med. 32 62-65 (1975).
- Maltoni, Cesare. Occupational Carcinogenesis
International Congress Series No. 322 (ISBN
90 219 02281) Cancer Detection and Prevention,
Proceedings of the Second International
Symposium, Bologna, (April 1973).
Another development was transmission privately of results from a series of pellet implant studies in rats with chromate materials at the Chester Beatty Institute in England.
The results of these studies singly or collectively are not regarded by DCMA as conclusive with respect to either lead chromate or zinc chromate. The results from the epidemiologic study of lead chromate workers are awaited before forming further judgment. These results will be sent to you as soon as possible.
As you requested I am sending you herewith copies of the notifications that are being presented to employees (Item VI) and to customers (Item V).
Attached also for your convenience are copies of the two recent publications.
| Very truly yours, [signature] James F. Morgan Consultant - Industrial Hygiene |
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
PUBLIC HEALTH SERVICE
CENTER FOR DISEASE CONTROL
SAFETY AND HEALTH
5600 FISHERS LANE
ROCKVILLE, MARYLAND 20852
October 7, 1975
Dear Colleague:
This is a further follow-up to information released by this office on June 24, 1975, concerning the potential carcinogenicity of chromate pigments.
On October 2, 1975, the Dry Color Manufacturers' Association (DCMA) informed NIOSH of the progress of an epidemiologic study sponsored by the DCMA and presented some preliminary results from an analysis of mortality data collected to date. These preliminary results are based on an examination of the relative frequency of deaths from cancer and other causes among the first 38 deaths identified by the researchers in a group of 580 workers exposed to lead chromate. Lung cancer was the cause of death for nearly 29 percent of the deceased workers. This figure was contrasted with estimates from other industrial populations in which lung cancer represented 7 to 9 percent of all deaths. Further review of the data revealed that lung cancer deaths accounted for 85 percent of all cancer deaths. These preliminary findings suggest an unusually high lung cancer risk among workers exposed to lead chromate pigments.
You will be kept apprised of future information as it becomes available.
| Sincerely yours, [signature] J. William Lloyd, Sc.D., Director Office of Occupational Health and Biometrics |
LEAD CHROMATE - AN UPDATE
On July 7, 1976, the National Institute for Occupational Safety and Health (NIOSH) received the final report of a study of lead chromate workers sponsored by the Dry Color Manufacturers' Association (DCMA). This report included final results of an epidemiologic study (preliminary results were reported by NIOSH in October 1975) along with the findings of an industrial hygiene study.
Prior to this, there have been limited reports (since 1940) of lung cancer among chrome pigment workers in Germany, Norway, and the United States. Studies of laboratory animals have indicated the potential for chrome pigments to produce tumors at the site of implantation or injection.
The study of lead chromate workers recently conducted for DCMA by Equitable Environmental Health, Inc., included three lead chromate plants in operation since the mid-1920's, 1941, and 1949, respectively. Employees of two plants were found to have had only lead chromate exposures, while workers in the third plant (analyzed separately) also had zinc chromate exposure. The industrial hygiene study of the three plants showed that nearly one-half of the samples reached or exceeded OSHA standards for lead and chromium. (The standards in effect at the time of this study were: for lead, 0.2 mg/m3; for chromium, soluble chromic, or chromous salts, .5 mg/m3 as Cr; and for chromic acid or chromates, 0.1 mg/m3 as Cr03).
The levels of lead and chromium found in this study were assumed to be lower than levels in the past because of some process changes and modifications of engineering controls and work practices; however, this difference could not be quantitated because of changes in analytical methods.
The three-plant cohort analysis included a total of 548 men among whom 53 deaths had occurred prior to December 31, 1974. Standardized mortality ratios (SMRs) were determined by comparing the observed deaths due to major causes with the number of expected deaths based on the 1960 male population of the state in which each plant was located. For all employees in two plants (with only lead chromate exposure), a 3-fold excess of respiratory cancer was observed (SMR 313.7 compared with an expected 100. Workers employed prior to 1960 (allowing for a 15-year "latency" period) were analyzed separately. For all persons in this group, regardless of length of employment, the SMR for respiratory cancer was 173.5; for persons who were hired prior to 1960 and who had worked there for at least 10 years, this SMR was 236.4.
Employees of the third plant (with both lead and zinc chromate exposure) were all hired before 1960 and had an SMR of 237.1 for respiratory cancer. In addition, 5 deaths due to stomach cancer were observed; this was 7 times the expected number.
Although the small number of observed deaths did not justify statistical tests, the Equitable Environmental Health researchers agree that this apparent excess of respiratory cancer in lead chromate workers is "consistent with the hypothesis that lead chromate is a respiratory carcinogen."
These findings are in accord with the NIOSH Criteria for a Recommended Standard on Hexavalent Chromium (December 1975) which states that lead chromate should be regarded as a human carcinogen.
|
[signature] John F. Finklea, M.D. Director |
Copies of this and other NIOSH documents are available from:
4676 Columbia Parkway
Cincinnati, OH 45226-1998
FAX (513) 533-8573
For further information about occupational safety and health, call
This page was last updated: 27, 1997
Go back to the
NIOSH home page
or to the CDC home page.
